Cite
Bujotzek A, Tiefenthaler G, Lariviere L, et al. Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential. Cell Chem Biol. 2021;doi: 10.1016/j.chembiol.2021.10.004.
Bujotzek, A., Tiefenthaler, G., Lariviere, L., D'Andrea, L., Marquez, E. A., Rudloff, I., Cho, S. X., Deen, N. S., Richter, W., Regenass-Lechner, F., Poehler, A., Whisstock, J. C., Sydow-Andersen, J., Reiser, X., Schuster, S., Neubauer, J., Hoepfl, S., Richter, K., Nold, M. F., Nold-Petry, C. A., Schumacher, F., & Ellisdon, A. M. (2021). Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential. Cell chemical biology, . https://doi.org/10.1016/j.chembiol.2021.10.004
Bujotzek, Alexander, et al. "Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential." Cell chemical biology vol. (2021). doi: https://doi.org/10.1016/j.chembiol.2021.10.004
Bujotzek A, Tiefenthaler G, Lariviere L, D'Andrea L, Marquez EA, Rudloff I, Cho SX, Deen NS, Richter W, Regenass-Lechner F, Poehler A, Whisstock JC, Sydow-Andersen J, Reiser X, Schuster S, Neubauer J, Hoepfl S, Richter K, Nold MF, Nold-Petry CA, Schumacher F, Ellisdon AM. Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential. Cell Chem Biol. 2021 Oct 19; doi: 10.1016/j.chembiol.2021.10.004. Epub 2021 Oct 19. PMID: 34699747.
Copy
Download .nbib